{"countAll":0,"orderType":null,"readLevel":"0","lyTopicReq":{"id":"1925","isDel":0,"createAt":0,"createBy":null,"createName":null,"updateAt":0,"updateBy":null,"updateName":null,"userId":null,"title":null,"content":null,"barId":"1925","topicTypeId":null,"topicThemeId":"1026","readLevel":0,"files":null,"clickNoLikeCount":0,"clickLikeCount":0,"clickCount":0,"score":0,"partCount":0,"replayCount":0,"publishStatus":0,"publishTime":0,"isCream":null,"canReply":0,"shareUrl":null,"foodCouponVal":0,"emailNotice":0,"permission":0,"zlyShare":0,"status":0,"sort":0,"highlight":0,"highlightEffectTime":0,"digest":0,"digestEffectTime":0,"top":0,"topEffectTime":0,"closed":0,"stamp":0,"icon":0,"bgcolor":null,"fontcolor":null,"favtimes":0,"isAdopt":0,"adoptId":null,"sortDate":0,"metaSearch":null,"rn":null},"lyBarModerators":{"list":[],"list4Map":null,"pageBegin":0,"pageSize":8,"pageNumber":0,"totalPage":0,"totalRow":0},"metaSearch":{"description":"为您提供:得乙肝的原因有哪些_乙肝是怎么引起的_乙肝引起原因_乙肝病友的治疗经验等相关信息，让病友在便捷的求医路上不花一分冤枉钱。","keywords":"得乙肝的原因有哪些_乙肝是怎么引起的_乙肝引起原因","title":"得乙肝的原因有哪些_乙肝是怎么引起的_乙肝引起原因","channels":null},"data":{"list":[{"id":"6984","isDel":0,"createAt":1509937260151,"createBy":"8abb11d0af1511e7a3d800163e04584d","createName":"良药苦口","updateAt":1525314977700,"updateBy":"8abb11d0af1511e7a3d800163e04584d","updateName":"良药苦口","userId":"8abb11d0af1511e7a3d800163e04584d","title":"你是乙肝高危人群吗 哪些人群容易被乙肝缠上","content":"

乙肝是属于一种难以治愈的疾病，但是预防乙肝却是一种很容易的事情。没有接种乙肝疫苗的人很容易感染上乙肝，一起去看看还有哪些人群容易被乙肝缠上。

\"你是乙肝高危人群吗

1、没有接种乙肝疫苗的人

接种乙肝疫苗，是预防乙肝的最为关键的措施。孩子在刚出生24小时内接种第一针乙肝疫苗，在新生儿满月和6个月时再接种第2、3针疫苗，产生的足量抗体至少能保护9-12年，甚至能够终身预防乙肝。出生时未接种乙肝疫苗的人可以在入托时、入学前或学龄期抓紧时间补充接种，成年时期查乙肝五项全阴时，应重复或补种乙肝疫苗3针，直到能查出抗体。

 

2、没有预防医源性传播理念的人

生病后切勿随便使用血液制品，采用一人一针一管一次性注射器材，是个人防治乙肝传染的第二道关口。需要做针灸、做直入性诊治手段的患者，一定要去有严格消毒条件的医院进行。

 

3、没有注意个人卫生的人

应养成良好的卫生习惯，饭前、便后以及摸过钱币后及时洗手；提倡个人生活用具、餐具只能个人使用，不用公共场所的剃须刀或刮脸刀；美容器材和美容用具要彻底消毒后一人一份，不能共用一份；不做文身，不穿耳孔；不随便到消毒不完善的门诊部拔牙、做小手术。

 

4、不懂得紧急防治乙肝措施的人

结婚前应该做婚前检查，对方带有乙肝病毒时，要检查自己有无保护性抗体。被带血的针头误伤时，应在24小时内注射乙肝免疫球蛋白。

 

5、不懂得防治乙肝病毒消毒措施的人

碗筷应该经常煮沸消毒，生活中常用肥皂洗手，可以达到一定的去污、防传染疾病的效果。

 

找良医网温馨提示：如有身体不适，请及时就医！


","barId":"1925","topicTypeId":"1","topicThemeId":"1026","readLevel":1,"files":"[]","clickNoLikeCount":0,"clickLikeCount":0,"clickCount":1451,"score":0,"partCount":0,"replayCount":0,"publishStatus":1,"publishTime":1509937260153,"isCream":0,"canReply":0,"shareUrl":null,"foodCouponVal":1,"emailNotice":0,"permission":0,"zlyShare":0,"status":0,"sort":0,"highlight":0,"highlightEffectTime":0,"digest":0,"digestEffectTime":0,"top":0,"topEffectTime":0,"closed":0,"stamp":0,"icon":0,"bgcolor":null,"fontcolor":null,"favtimes":0,"isAdopt":0,"adoptId":null,"sortDate":1509937260153,"metaSearch":null,"rn":0,"barTitle":null,"checkcode":null,"forumUser":{"id":"8abb11d0af1511e7a3d800163e04584d","isDel":0,"createAt":1507789271266,"createBy":null,"createName":null,"updateAt":0,"updateBy":null,"updateName":null,"username":"良药苦口","password":"zx13401068656","level":0,"nickName":"周良药","realName":null,"signName":"良药苦口利于病，忠言逆耳利于行！","head":"http://01luntan.com/ly_img/1516263139285.jpg","phone":null,"mobile":null,"wechat":null,"qq":null,"email":"langlixunta@163.com","address":null,"identityType":6,"userType":2,"isPhoneBind":0,"status":0,"accountSource":0,"isStrangerMsg":0,"departmentId":null,"departmentName":null,"sex":1,"provinceId":"110000","cityId":"110114","userLevel":0,"modifyNameCount":1},"lyTopicReply":null,"createAtStr":null,"lyBar":null,"lyTopic":null},{"id":"4232","isDel":0,"createAt":1489579178108,"createBy":"84404015eff611e6a61c00163e04584d","createName":"13911686944","updateAt":0,"updateBy":null,"updateName":null,"userId":"84404015eff611e6a61c00163e04584d","title":"乙肝血清全国人群流行病学调查","content":"

　　为掌握我国现阶段不同地区、不同人群乙肝表面抗原携带率和乙肝病毒感染率，评价1992年我国乙肝疫苗纳入儿童计划免疫管理和2002年乙肝疫苗纳入儿童免疫规划的效果。2006由卫生部统一组织实施，中国疾病预防控制中心负责调查方案设计及技术指导，在全国人群开展了乙肝等有关疾病血清流行病学调查。相关调查结果表明：现阶段我国乙肝的免疫预防工作取得显著成绩。

　　据了解，该调查在全国范围的160个“疾病监测点”上进行。采用多阶段随机抽样方法进行调查，抽取东部、中部、西部地区的城市、农村的1～59岁共计81775余人。

\"timg

　　卫生部公布了本次调查的结果：

　　一、相关人群乙肝表面抗原携带率为7.18%。城市、农村人群乙肝表面抗原携带率差异不显著，在地域方面，乙肝表面抗原携带率东部地区略低。1～4岁人群乙肝表面抗原携带率最低，15～59岁人群乙肝表面抗原携带率最高达8.57%。1～4岁人群乙肝表面抗原携带率明显低于15～59岁人群。

　　二、调查人群乙肝抗体阳性率为50.09%。城市高于农村，西部高于东部地区。1～4岁人群乙肝抗体阳性率最高，为71.24%，而15～59岁人群最低，为47.38%。

\"timg

　　三、本次乙肝疫苗接种调查显示：1～14岁儿童40129人，占81.56%。1～4岁和5～14岁调查人群乙肝疫苗全程接种率为89.39%和50.59%，乙肝疫苗首针及时接种率分别为73.37%和43.91%，乙肝疫苗全程和首针及时接种率城市高于农村，东部高于西部。

　　四、乙肝疫苗免疫与乙肝表面抗原携带方面：疫苗接种史人群表面抗原携带率明显低于无乙肝疫苗接种史人群。在有预防接种史的儿童中，首针乙肝疫苗及时接种者乙肝表面抗原携带率低于未及时接种人群。

\"timg

　　本次流行病学调查结果提示：乙肝免疫预防工作取得显著成绩：

　　一、乙肝表面抗原携带率大幅下降，与1992年调查发现的9.75%的乙肝表面抗原携带率相比，下降26.36%，根据1992年和2006年两次血清流行病学调查结果估计，1992年以来儿童感染乙肝病毒的人数减少了近8000万人，儿童乙肝表面抗原携带者减少了1900万人。

　　二、乙肝疫苗全程接种率由1992年乙肝疫苗纳入免疫规划管理时的30%提高到2005年出生儿童的93%。

　　我国人口众多，随着人均寿命提高，大量乙肝表面抗原携带者终身携带，成人的乙肝表面抗原携带率不会出现明显下降。受预防保健服务可及性的限制，导致首针及时接种率难度较大。

　　卫生部将结合本次调查结果，进一步加大乙肝预防控制工作。逐步开展新生儿以外人群乙肝疫苗预防接种工作，鼓励对重点人群、高危人群接种乙肝疫苗，通过提高中西部农村地区孕产妇住院分娩率，以提高乙肝疫苗首针及时接种率。


","barId":"1925","topicTypeId":"1","topicThemeId":"1026","readLevel":0,"files":"","clickNoLikeCount":0,"clickLikeCount":0,"clickCount":1674,"score":0,"partCount":0,"replayCount":0,"publishStatus":1,"publishTime":1489579178109,"isCream":0,"canReply":0,"shareUrl":null,"foodCouponVal":1,"emailNotice":0,"permission":0,"zlyShare":0,"status":0,"sort":0,"highlight":0,"highlightEffectTime":0,"digest":0,"digestEffectTime":0,"top":0,"topEffectTime":0,"closed":0,"stamp":0,"icon":0,"bgcolor":null,"fontcolor":null,"favtimes":0,"isAdopt":0,"adoptId":null,"sortDate":1489579178108,"metaSearch":null,"rn":0,"barTitle":null,"checkcode":null,"forumUser":{"id":"84404015eff611e6a61c00163e04584d","isDel":0,"createAt":1486775274108,"createBy":null,"createName":null,"updateAt":0,"updateBy":null,"updateName":null,"username":"13911686944","password":"000000","level":0,"nickName":"赵金亮","realName":null,"signName":"c","head":null,"phone":"13911686944","mobile":null,"wechat":null,"qq":null,"email":null,"address":null,"identityType":6,"userType":2,"isPhoneBind":1,"status":0,"accountSource":0,"isStrangerMsg":0,"departmentId":null,"departmentName":null,"sex":1,"provinceId":"110000","cityId":"","userLevel":0,"modifyNameCount":1},"lyTopicReply":null,"createAtStr":null,"lyBar":null,"lyTopic":null},{"id":"4489","isDel":0,"createAt":1489574482800,"createBy":"84404015eff611e6a61c00163e04584d","createName":"13911686944","updateAt":0,"updateBy":null,"updateName":null,"userId":"84404015eff611e6a61c00163e04584d","title":"乙肝治疗费用医保能报销最新进展","content":"

世界卫生组织的数据显示，全球大约有2.4亿人慢性感染乙肝，每年估计有超过78万人死于肝硬化和肝癌等乙肝并发症。中国约有9000万乙肝病毒慢性感染者，除了长期担负医疗费用外，他们还可能在入学、就业等各方面遭到歧视。

但是，在包括中国在内的许多国家，患者的经济承受能力仍然是个问题，罗氏也正在寻找各种解决方案。

“我们已和一些省政府达成协议，将罗氏的药物列入省级医保目录。” 弗兰茨说。目前，赫赛汀在11个省份可以报销，覆盖3.5亿人口。

然而，即使在一个省内，报销比例也不尽相同。“在浙江省的不同城市，赫赛汀的医保报销比例从50%到80%不等，这取决于每个城市的财政预算。”

    在《国家基本医疗保险、工伤保险和生育保险药品目录》中明确规定用于治疗乙肝的长效干扰素是可以报销的，令人遗憾的是截止目前为止，依然有疗程限制，口服核苷类似物来治疗乙肝的可以报销的是拉米夫定、替比夫定和恩替卡韦这三种药物。

\"1.jpg\"/

   对城乡居民患者来讲需要注意的是：乙肝治疗费用医保能报销须是以已经参加农村合作医疗保险为前提，也就是说只有在参加农村合作医疗保险情况下，才可以报销乙肝治疗费用。另外在报销比例方面也是有一定限制的，并不是百分百报销！

 


","barId":"1925","topicTypeId":"1","topicThemeId":"1026","readLevel":0,"files":"","clickNoLikeCount":0,"clickLikeCount":0,"clickCount":2566,"score":0,"partCount":0,"replayCount":0,"publishStatus":1,"publishTime":1489574482801,"isCream":0,"canReply":0,"shareUrl":null,"foodCouponVal":1,"emailNotice":0,"permission":0,"zlyShare":0,"status":0,"sort":0,"highlight":0,"highlightEffectTime":0,"digest":0,"digestEffectTime":0,"top":0,"topEffectTime":0,"closed":0,"stamp":0,"icon":0,"bgcolor":null,"fontcolor":null,"favtimes":0,"isAdopt":0,"adoptId":null,"sortDate":1489574482800,"metaSearch":null,"rn":0,"barTitle":null,"checkcode":null,"forumUser":{"id":"84404015eff611e6a61c00163e04584d","isDel":0,"createAt":1486775274108,"createBy":null,"createName":null,"updateAt":0,"updateBy":null,"updateName":null,"username":"13911686944","password":"000000","level":0,"nickName":"赵金亮","realName":null,"signName":"c","head":null,"phone":"13911686944","mobile":null,"wechat":null,"qq":null,"email":null,"address":null,"identityType":6,"userType":2,"isPhoneBind":1,"status":0,"accountSource":0,"isStrangerMsg":0,"departmentId":null,"departmentName":null,"sex":1,"provinceId":"110000","cityId":"","userLevel":0,"modifyNameCount":1},"lyTopicReply":null,"createAtStr":null,"lyBar":null,"lyTopic":null},{"id":"2594","isDel":0,"createAt":1489573838585,"createBy":"84404015eff611e6a61c00163e04584d","createName":"13911686944","updateAt":0,"updateBy":null,"updateName":null,"userId":"84404015eff611e6a61c00163e04584d","title":"乙肝新药研发获得重大突破","content":"

乙肝治疗在全球范围内依然是世界性难题，尚无根治之法，目前只能通过长期服药来控制病情。全球最大的生物技术公司罗氏上海研发中心针对乙肝病毒的药物研发，其水平毫不逊色于罗氏在欧美的实验室，在世界范围内都属前沿。最近来自其上海研发中心的科学家们通过努力，在有望彻底治愈乙肝的新药研发上取得了“重大进展”。

“我们还不知道这一批候选新药是否对人类奏效，但动物试验很成功，看起来很有希望。”罗氏集团董事会主席克里斯托弗·弗兰茨博士近日在接受新华社记者专访时透露，“科学家们将很快对新药开展临床试验。”

据了解，该新药将通过结合两种机制来达到共同对抗乙肝病毒目的，既可以针对病毒进行靶向治疗，也可以针对免疫系统进行激活疗法。

\"timg

“如果早期临床试验成功的话，新药至少还需要三至四年，才能进入市场。” 弗兰茨说，“不过，新药研发也存在极高的风险，十个中九个在临床阶段会面临失败的命运。”

\"timg


找良医网希望该药能早日上市，以解患者之病痛！



","barId":"1925","topicTypeId":"1","topicThemeId":"1026","readLevel":0,"files":"","clickNoLikeCount":0,"clickLikeCount":0,"clickCount":1571,"score":0,"partCount":0,"replayCount":0,"publishStatus":1,"publishTime":1489573838590,"isCream":0,"canReply":0,"shareUrl":null,"foodCouponVal":1,"emailNotice":0,"permission":0,"zlyShare":0,"status":0,"sort":0,"highlight":0,"highlightEffectTime":0,"digest":0,"digestEffectTime":0,"top":0,"topEffectTime":0,"closed":0,"stamp":0,"icon":0,"bgcolor":null,"fontcolor":null,"favtimes":0,"isAdopt":0,"adoptId":null,"sortDate":1489573838585,"metaSearch":null,"rn":0,"barTitle":null,"checkcode":null,"forumUser":{"id":"84404015eff611e6a61c00163e04584d","isDel":0,"createAt":1486775274108,"createBy":null,"createName":null,"updateAt":0,"updateBy":null,"updateName":null,"username":"13911686944","password":"000000","level":0,"nickName":"赵金亮","realName":null,"signName":"c","head":null,"phone":"13911686944","mobile":null,"wechat":null,"qq":null,"email":null,"address":null,"identityType":6,"userType":2,"isPhoneBind":1,"status":0,"accountSource":0,"isStrangerMsg":0,"departmentId":null,"departmentName":null,"sex":1,"provinceId":"110000","cityId":"","userLevel":0,"modifyNameCount":1},"lyTopicReply":null,"createAtStr":null,"lyBar":null,"lyTopic":null},{"id":"1287","isDel":0,"createAt":1487506517639,"createBy":"84404015eff611e6a61c00163e04584d","createName":"13911686944","updateAt":0,"updateBy":null,"updateName":null,"userId":"84404015eff611e6a61c00163e04584d","title":"江苏高考体检今年取消乙肝项目检测","content":"

　　荔枝全媒体记者陆啸/荔枝新闻记者今天（2月18日）从省教育考试院获悉，我省2017年普通高校招生体检工作即将启动。今年体检的具体办法和军校招生办法也已公布。


　　根据我省2017年高招体检办法，今年将取消乙肝项目检测，即取消乙肝病毒感染标志物检测，包括乙肝病毒表面抗原、乙肝病毒表面抗体、乙肝病毒e抗原、乙肝病毒e抗体、乙肝病毒核心抗体和乙肝病毒脱氧核糖核苷酸检测等，俗称“乙肝五项”和HBV-DNA检测；继续保留丙氨酸氨基转移酶（ALT，简称转氨酶）检测作为体检项目。如果受检者转氨酶正常，不得进行乙肝项目检测；如果转氨酶在100单位以上，则进行乙肝项目检测，如表面抗原阳性，体检一个月后复检，复检结论仍不正常的考生，体检结论为不合格。


　　据了解，2017年军事院校军检、面试和公安院校的面试、体能测试工作仍在高考结束后进行。


","barId":"1925","topicTypeId":"1","topicThemeId":"1026","readLevel":0,"files":"","clickNoLikeCount":0,"clickLikeCount":0,"clickCount":1863,"score":0,"partCount":0,"replayCount":0,"publishStatus":1,"publishTime":1487506517641,"isCream":0,"canReply":0,"shareUrl":null,"foodCouponVal":1,"emailNotice":0,"permission":0,"zlyShare":0,"status":0,"sort":0,"highlight":0,"highlightEffectTime":0,"digest":0,"digestEffectTime":0,"top":0,"topEffectTime":0,"closed":0,"stamp":0,"icon":0,"bgcolor":null,"fontcolor":null,"favtimes":0,"isAdopt":0,"adoptId":null,"sortDate":1487506517639,"metaSearch":null,"rn":0,"barTitle":null,"checkcode":null,"forumUser":{"id":"84404015eff611e6a61c00163e04584d","isDel":0,"createAt":1486775274108,"createBy":null,"createName":null,"updateAt":0,"updateBy":null,"updateName":null,"username":"13911686944","password":"000000","level":0,"nickName":"赵金亮","realName":null,"signName":"c","head":null,"phone":"13911686944","mobile":null,"wechat":null,"qq":null,"email":null,"address":null,"identityType":6,"userType":2,"isPhoneBind":1,"status":0,"accountSource":0,"isStrangerMsg":0,"departmentId":null,"departmentName":null,"sex":1,"provinceId":"110000","cityId":"","userLevel":0,"modifyNameCount":1},"lyTopicReply":null,"createAtStr":null,"lyBar":null,"lyTopic":null},{"id":"3571","isDel":0,"createAt":1487506352514,"createBy":"84404015eff611e6a61c00163e04584d","createName":"13911686944","updateAt":0,"updateBy":null,"updateName":null,"userId":"84404015eff611e6a61c00163e04584d","title":"乙肝患者新希望：乙肝或实现“临床治愈”","content":"

  目前我国有近8000万乙型肝炎病毒（HBV）慢性感染者，近2000万为慢性乙肝患者，治疗人群超过200万。为了减少停药带来的疾病复发和反弹，各国和地区的慢乙肝防治指南多强调对慢性乙肝患者长期用药。据北京大学医学部病原生物学系主任鲁凤民教授介绍，实际上，有一部分患者（约20%）停药后并不会反弹。基于血清HBV RNA持续消失为实验室诊断指标的“准临床治愈”概念如果能经多中心的大队列验证，未来可用于鉴别这些可以安全停药的患者。


      在日前召开的2016年亚太肝病研究学会第六届乙肝专题会议上，鲁凤民报告了他们与厦门大学等单位的合作研究成果，并提出慢性乙型肝炎“安全停药”和“准临床治愈”新观点。该研究2016年相继刊发在欧洲肝病学会会刊《肝脏学杂志》。在过去的两年时间中，鲁凤民实验室通过一系列研究，阐明了慢乙肝停药后复发、乙肝病毒复制模板等相关性研究。

据介绍，未来在国家“十三五”专项支持下，鲁凤民课题组将对血清HBV RNA的临床意义进行系统研究，以验证该“准临床治愈”和基于此的安全停药的可行性，并推出中国慢乙肝临床治愈线路图。

本文来源：人民网-人民日报海外版

","barId":"1925","topicTypeId":"1","topicThemeId":"1026","readLevel":0,"files":"","clickNoLikeCount":0,"clickLikeCount":0,"clickCount":1879,"score":0,"partCount":0,"replayCount":0,"publishStatus":1,"publishTime":1487506352515,"isCream":0,"canReply":0,"shareUrl":null,"foodCouponVal":1,"emailNotice":0,"permission":0,"zlyShare":0,"status":0,"sort":0,"highlight":0,"highlightEffectTime":0,"digest":0,"digestEffectTime":0,"top":0,"topEffectTime":0,"closed":0,"stamp":0,"icon":0,"bgcolor":null,"fontcolor":null,"favtimes":0,"isAdopt":0,"adoptId":null,"sortDate":1487506352514,"metaSearch":null,"rn":0,"barTitle":null,"checkcode":null,"forumUser":{"id":"84404015eff611e6a61c00163e04584d","isDel":0,"createAt":1486775274108,"createBy":null,"createName":null,"updateAt":0,"updateBy":null,"updateName":null,"username":"13911686944","password":"000000","level":0,"nickName":"赵金亮","realName":null,"signName":"c","head":null,"phone":"13911686944","mobile":null,"wechat":null,"qq":null,"email":null,"address":null,"identityType":6,"userType":2,"isPhoneBind":1,"status":0,"accountSource":0,"isStrangerMsg":0,"departmentId":null,"departmentName":null,"sex":1,"provinceId":"110000","cityId":"","userLevel":0,"modifyNameCount":1},"lyTopicReply":null,"createAtStr":null,"lyBar":null,"lyTopic":null}],"list4Map":null,"pageBegin":0,"pageSize":25,"pageNumber":1,"totalPage":1,"totalRow":6},"focus":0,"userDtos":[],"currCount":0,"lyBar":{"id":"1925","isDel":0,"createAt":1483430797988,"createBy":"system","createName":"system","updateAt":0,"updateBy":null,"updateName":null,"userId":null,"name":"乙肝","type":102,"twoCode":"http://zhao01.com/zly_img/zly_wx.jpg","image":null,"provinceId":null,"cityId":null,"illId":"0cda4cb3badb11e6a61c00163e04584d","hospitalId":null,"keyWord":null,"totleTopic":0,"barDesc":null,"discussBarType":null,"metaSearch":"{\"channels\":{\"病友社区\":{\"description\":\"为您提供:乙肝论坛贴吧乙肝交流论坛_乙肝交流肝胆相照论坛等相关信息，让病友在便捷的求医路上不花一分冤枉钱。\",\"keywords\":\"乙肝论坛贴吧乙肝交流论坛_乙肝交流肝胆相照论坛\",\"title\":\"乙肝论坛贴吧乙肝交流论坛_乙肝交流肝胆相照论坛\"},\"治疗\":{\"description\":\"为您提供:得了乙肝怎么治疗_乙肝如何治疗_乙肝如果不治疗会怎样_乙肝病友的治疗经验等相关信息，让病友在便捷的求医路上不花一分冤枉钱。\",\"keywords\":\"得了乙肝怎么治疗_乙肝如何治疗_乙肝如果不治疗会怎样\",\"title\":\"得了乙肝怎么治疗_乙肝如何治疗_乙肝如果不治疗会怎样\"},\"症状\":{\"description\":\"为您提供:乙肝症状表现有哪些_刚得了乙肝有什么症状乙肝病友的治疗经验等相关信息，让病友在便捷的求医路上不花一分冤枉钱。\",\"keywords\":\"乙肝症状表现有哪些_刚得了乙肝有什么症状\",\"title\":\"乙肝症状表现有哪些_刚得了乙肝有什么症状\"},\"并发症\":{\"description\":\"为您提供:乙肝并发症包括哪些_乙肝会引起什么并发症_乙肝病友的治疗经验等相关信息，让病友在便捷的求医路上不花一分冤枉钱。\",\"keywords\":\"乙肝并发症包括哪些_乙肝会引起什么并发症\",\"title\":\"乙肝并发症包括哪些_乙肝会引起什么并发症\"},\"饮食\":{\"description\":\"为您提供:慢性乙肝吃什么食物_乙肝不能吃什么水果_乙肝病友的饮食经验等相关信息，让病友在便捷的求医路上不花一分冤枉钱。\",\"keywords\":\"慢性乙肝吃什么食物_乙肝不能吃什么水果\",\"title\":\"慢性乙肝吃什么食物_乙肝不能吃什么水果\"},\"病因\":{\"description\":\"为您提供:得乙肝的原因有哪些_乙肝是怎么引起的_乙肝引起原因_乙肝病友的治疗经验等相关信息，让病友在便捷的求医路上不花一分冤枉钱。\",\"keywords\":\"得乙肝的原因有哪些_乙肝是怎么引起的_乙肝引起原因\",\"title\":\"得乙肝的原因有哪些_乙肝是怎么引起的_乙肝引起原因\"},\"病友求助\":{\"description\":\"为您提供:入职体检有乙肝怎么办_老婆有乙肝怎么办_乙肝病友的治疗经验等相关信息，让病友在便捷的求医路上不花一分冤枉钱。\",\"keywords\":\"入职体检有乙肝怎么办_老婆有乙肝怎么办\",\"title\":\"入职体检有乙肝怎么办_老婆有乙肝怎么办\"},\"预防\":{\"description\":\"为您提供:家里有乙肝要注意什么_怎样预防乙肝病毒传染_乙肝病友的预防经验等相关信息，让病友在便捷的求医路上不花一分冤枉钱。\",\"keywords\":\"家里有乙肝要注意什么_怎样预防乙肝病毒传染\",\"title\":\"家里有乙肝要注意什么_怎样预防乙肝病毒传染\"}},\"description\":\"为您提供:乙肝大三阳能治愈吗、乙肝小三阳是什么意思、乙肝携带者能生小孩吗、乙肝病友的治疗经验等相关信息，让病友在便捷的求医路上不花一分冤枉钱。\",\"keywords\":\"乙肝大三阳能治愈吗_乙肝小三阳是什么意思_乙肝携带者能生小孩吗\",\"title\":\"乙肝大三阳能治愈吗_乙肝小三阳是什么意思_乙肝携带者能生小孩吗\"}","adInfo":null},"foodCouponValThan":null,"zlyTopic":{"id":"1925","isDel":0,"createAt":0,"createBy":null,"createName":null,"updateAt":0,"updateBy":null,"updateName":null,"userId":null,"title":null,"content":null,"barId":"1925","topicTypeId":null,"topicThemeId":"1026","readLevel":0,"files":null,"clickNoLikeCount":0,"clickLikeCount":0,"clickCount":0,"score":0,"partCount":0,"replayCount":0,"publishStatus":0,"publishTime":0,"isCream":null,"canReply":0,"shareUrl":null,"foodCouponVal":0,"emailNotice":0,"permission":0,"zlyShare":0,"status":0,"sort":0,"highlight":0,"highlightEffectTime":0,"digest":0,"digestEffectTime":0,"top":0,"topEffectTime":0,"closed":0,"stamp":0,"icon":0,"bgcolor":null,"fontcolor":null,"favtimes":0,"isAdopt":0,"adoptId":null,"sortDate":0,"metaSearch":null,"rn":null},"pageTopics":{"list":[],"list4Map":null,"pageBegin":0,"pageSize":10,"pageNumber":0,"totalPage":0,"totalRow":0},"herfList":[],"forumUserFocusBar":{"id":null,"isDel":0,"createAt":0,"createBy":null,"createName":null,"updateAt":0,"updateBy":null,"updateName":null,"userId":null,"barId":null,"barName":null,"barType":0,"webType":0,"userType":0}}